• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down 3.39% Nasdaq Down 4.12%

    Intercept Pharmaceuticals, Inc. (ICPT)

    -NasdaqGS
    142.92 Down 11.34(7.35%) Jun 24, 4:00PM EDT
    |After Hours : 142.97 Up 0.05 (0.03%) Jun 24, 7:49PM EDT
    Prev Close:154.26
    Open:144.56
    Bid:142.97 x 100
    Ask:173.33 x 100
    1y Target Est:221.56
    Beta:-2.4377
    Earnings Date:Aug 3 - Aug 8 (Est.)
    Day's Range:142.47 - 150.50
    52wk Range:89.76 - 285.00
    Volume:744,208
    Avg Vol (3m):605,806
    Market Cap:3.52B
    P/E (ttm):N/A
    EPS (ttm):-12.92
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ICPT

    Comparison

    Symbol% ChgMkt Cap
    ICPTDown 7.35%3.52B
    SLXP 0.00%10.88B
    AZNDown 4.88%70.49B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):2,129.08
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-16.48
    Quarterly EPS Est (Jun-16) :-3.68
    Mean Recommendation*:2.1
    PEG Ratio (5 yr expected):-1.34

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat non-viral, progressive liver diseases. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback